Budesonide/Arformoterol

布地奈德/阿福特罗

Report date: 2025/11/27 15:17:48

Base Information

Drug NameBudesonide/Arformoterol
Drug Alias NameUI-030
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsGlucocorticoid receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BudesonideArformoterol Tartrate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKorea United Pharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea United Pharm Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A